SCHEMBL21369994

SCHEMBL21369994

C1=CCC2(C=C1)CCCCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4527065 0.97
SCHEMBL17653472 0.86
SCHEMBL6534020 0.83
SCHEMBL11773606 0.83
SCHEMBL11773086 0.83
SCHEMBL11775916 0.80
SCHEMBL23126517 0.78
SCHEMBL3033207 0.76
SCHEMBL3277733 0.74
SCHEMBL20888200 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240425974-A1 DEPOSITION OF RUTHENIUM-CONTAINING FILMS BY NON-AROMATIZABLE CYCLIC-DIENE RUTHENIUM(0) COMPLEXES LAIR LIQUIDE SA POUR IEXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2024-12-26 US disclosed
WO-2024259111-A1 DEPOSITION OF RUTHENIUM-CONTAINING FILMS BY NON-AROMATIZABLE CYCLIC-DIENE RUTHENIUM(0) COMPLEXES L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2024-12-19 WO disclosed
WO-2022268152-A1 GLP-1 RECEPTOR AGONIST AND COMPOSITION AND USE THEREOF 杭州中美华东制药有限公司 2022-12-29 WO disclosed
US-20210198220-A1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-07-01 US disclosed
US-11001563-B2 SSAO inhibitor SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-05-11 US disclosed
US-10717720-B2 Modified compound of andrographolide HEILONGJIANG ZHENBAODAO PHARMACEUTICAL CO., LTD. (CN) 2020-07-21 US disclosed
US-20200115352-A1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO., LTD. 2020-04-16 US disclosed
WO-2019174576-A1 IMIDAXOPYROLONE COMPOUND AND APPLICATION THEREOF 罗欣药业(上海)有限公司 2019-09-19 WO disclosed